Progressive Care has broken strongly out of the st
Post# of 1525
The company is now profitable and has cleared all debt from the balance sheet in 2015. Debt was accumulated from initial founding in 2007 through 2014, while building a strong core business and consistently increasing year over year revenue, to the current level of ~$15M (annualized).
The company is currently at $15M net sales with a market cap of only $6.65M. Part of this is due to a previously depressed pps while the stock was being diluted to pay down the debt, in combination with the prior "OTC Pink Limited Info" status (yield sign on OTC Markets). A price correction is ongoing since the "zero debt" milestone in December, and the yield sign was removed just last week on Jan 8 as RXMD was upgraded to "Current Information."
The COO was just promoted to CEO after a solid performance as COO, and will be agressively pursuing the vision of PharmCo as a national brand through 2016 and beyond.
As a profitable business in a high-demand, high-growth, high-margin market with zero debt and a flawless record of QoQ and YoY revenue growth over the past 3 years, Progressive Care is well-positioned to replicate the PharmCo "franchise" model to achieve this national PharmCo brand vision.